CD8A and neoplasm: The binding of PD‐1 to PD‐L1/L2 inhibits tumor cell apoptosis, promotes the conversion of effector T cells into T regulatory cells (Tregs), and suppresses the activity of CD8+ T cells, reducing their ability to maintain tumor cell dormancy.12